Increasing evidence indicates that apoptosis can be associated with several viral infections. Here we demonstrate, that infection of monocytoid cells by Herpes simplex virus 2 (HSV-2) resulted, in time-and dose-dependent induction of apoptosis as an exclusive cytopathic effect. The phenomenon was confirmed using four different techniques. Conversely, apoptosis was not observed in the Vero cell line. Virus yield in monocytoid cells was delayed and reduced, although well detectable, in comparison with that observed in Vero cells. Nevertheless, released virions exhibited full infecting capability. Apoptosis induced by HSV-2 was not inhibited by cycloheximide and only partially by an UV-treatment which completely abrogated infectivity. Virus-induced apoptosis was partly inhibited by indomethacin and was associated with a down-regulation of Bcl-2. A similar, but less pronounced, apoptosis-inducing effect in monocytoid cells was also observed with HSV-1 infection. Depending on the target cells, therefore, HSV could complete a cycle of infection which is characterized by apoptosis of infected cells.
Introduction
Mechanisms involved in the cytopathic effect of viruses during infection are largely unknown. Viruses were considered to cause cell death by destroying cell membrane, by cell fusion, or by lethal damage of host cell transcriptional or translational machinery. As a consequence, cell necrosis, which can result from these events during productive replication, was supposed, in the past, to be the exclusive form of cell death associated with viral infection. However, increasing evidence suggets that apoptosis, the cellular mechanism of selfdestruction triggered by either physiological or pathological stimuli (Kerr et al, 1972; Arends and Wyllie, 1991) , may occur during several viral infections, including those caused by members of the Herpesviridae family (reviewed in McCabe and Orrenius, 1992; Razvi and Welsh, 1995; Shen and Shenk, 1995) . In particular, herpes simplex virus 1 (HSV-1), a member of Alphaherpesvirinae subfamily, has been associated, similarly to members of other virus families, with both apoptosis-inducing and apoptosis-preventing actions (Chou and Roizman, 1992; Tropea et al, 1995) . The different fate of target cells has recently been attributed to whether or not the virus is able to express genes codifying for proteins exerting anti-apoptotic actions (Leopardi and Roizman, 1996) . Herpes simplex virus 2 (HSV-2), is another member of the Alphaherpesvirinae subfamily of herpesviruses, characterized by a variable host range, a short replicative cycle and rapid cell to cell spread in culture. Moreover, infection by HSV-2 is characterized, similarly to that caused by HSV-1, by the ability of the virus to establish a wide spectrum of relationships with infected tissues, ranging from a latent form of silent infection to rapid induction of death in infected cells (Roizman and Sears, 1996) .
In the present study we have investigated the role of the cellular target in the processes which may or may not lead to cell death by apoptosis in infections caused by herpes simplex viruses. To this purpose we have principally used the in vitro infection of human monocytoid cells with HSV-2, compared to that of fully permissive Vero cells, as an experimental model.
Results

Herpes simplex virus type 2 induces apoptosis of monocytoid cells
Results showed a marked increase in the percentage of apoptotic cells following HSV-2 infection, when compared with control uninfected or mock-infected cells, using morphological analysis by light microscopy and acridine orange or Hoechst staining. In the experiment shown in Figure 1 , the level of apoptosis reached about 33%, 48 h post infection (p.i.) (Figure 1b and d) . Uninfected controls showed a low level of spontaneous apoptosis (52%) (Figure 1a and c), as did mock-infected cells (data not shown). In order to confirm the above-reported results, we utilized flow cytometry analysis of isolated nuclei, a highly reproducible and quantitative technique to detect apoptosis. Results unconfutably confirmed morphological analysis. In the experiment shown in Figure 2 , the percentage of hypodiploid nuclei obtained from control cells, after 48 h of culture, was still rather low (4%, Figure 2a ), while hypodiploid nuclei obtained from cells infected with HSV-2 with a multiplicity of infection (MOI) of 10 plaque forming units (PFU)/cell rose to 71% (Figure 2b ). Apoptosis in U937 cells infected with HSV-2 was also evaluated by using the TUNEL technique, an assay able to directly detect DNA fragmentation at single cell level. In the experiment illustrated in Figure 2 (from c to f), 48 h after infection we obtained 26% positive apoptotic cells from the culture infected at a MOI of 1 PFU/cell ( Figure 2e ) and 61% positive apoptotic cells from the culture infected at a MOI of 10 PFU/cell (Figure 2f ), in comparison with 14% positive cells from the mock-infected culture ( Figure 2c ) and 96% in the positive control consisting of DNase I-treated cells ( Figure  2d ).
Kinetic, dose-dependency of herpes simplex type 2-induced apoptosis and comparison with herpes simplex type 1
The induction of apoptosis in U937 by HSV-2 was dependent on the dose of virus inoculum and on the length of time of culture following infection. Table 1 summarizes the kinetic, dose-dependency and variability of the phenomenon of HSV-2-induced apoptosis in U937 monocytoid cells, resulting from mean values of % apoptosis plus SD obtained from three independent experiments. Apoptosis induced by HSV-2 at various PFU/cell ratios was evaluated by fluorescence microscopy analysis of cells after staining with acridine orange, as described below. At a high MOI we observed, within 72 h p.i., a level of apoptosis, comprising practically all the cells in culture. Again in Table 1 , we can compare the results obtained when the`F' strain of HSV-1 was utilized in place of HSV-2, showing a similar but less pronounced apoptosis-inducing effect.
Herpes simplex type 2 does not induce apoptosis in Vero cells
Moreover, in order to verify whether HSV-2 infection of U937 could result in complete cleavage of nuclear DNA into oligonucleosome-sized fragments, considered as the ultimate event of apoptosis, we utilized the DNA-electrophoresis-on-agarose-gel technique. Results reported in Figure 3 show the presence of the typical apoptotic`DNA ladder' in U937 cells infected with HSV-2 at a MOI of 10 PFU/cell 48 h p.i. The same experiment showed no evidence of apoptosis in the fully permissive Vero cell line tested at different times following infection with HSV-2, extending to HSV-2 what has been recently demonstrated for HSV-1 in the same cell line (Leopardi and Roizman, 1996). The resistance of Vero cells to HSV-2-induced apoptosis was confirmed by repeated failure to detect any evidence of apoptosis, using all the above reported techniques (data not shown). Unexpectedly, in some preliminary experiments using a U937 cell line of different origin in respect to that utilized in all the experiments shown in this report, while all other assays showed the presence of apoptotic cells in cultures infected with HSV-2, only the gel electrophoresis technique did not give the same result (data not shown). We were unable to understand the exact reasons for this discrepancy, but they are probably related to a characteristic peculiar to the cell line utilized, as previously described for U937 following a different inducing stimulus (Ghibelli et al, 1995) . However, no evidence of cell death other than optosis was observed in cultures of U937 cells infected with herpes simplex viruses and analyzed in the above-reported or in any other experiment. Moreover, time-and dosedependent induction of apoptosis by HSV-2 was also observed in HL-60 monocytoid cells (data not shown). or from U937 cells infected with HSV-2 at a MOI of 10 PFU/cell (B) were isolated and stained by treatment with a solution consisting of propidium iodide (50 mg/ml), sodium citrate (0.1%) and Triton X-100 (1%) in distilled water and analyzed by flow cytometry. The dashed lines indicate the boundaries between the peaks of hypodiploid and diploid nuclei which were arbitrarily set on the control sample and maintained in the corresponding infected sample. In another experiment DNA fragmentation was analyzed at single cel level by flow cytometry using the TUNEL technique, after 48 h of culture in control U937 cells (C) or in U937 cells infected with HSV-2 at a MOI of 1 PFU/cell (E) or at a MOI of 10 PFU/cell (F). Results were compared with a positive control consisting of DNase I (1 mg/ml) treated U937 cells (D). The dashed lines indicate the boundaries between the peaks of negative and positive cells which were arbitrarily set in control samples incubated with FITC-dUTP solution alone, without TdT, and maintained in all the corresponding fluorescein-dUTP/Tdt-treated samples. Detection of apoptosis using propidium iodide staining and the TUNEL technique were repeated in four and two independent experiments, respectively, with similar results HSV-2-induced apoptosis in monocytoid cells is associated with productive infection and inhibition of protein synthesis, at lower levels than those observed in Vero cells
Considering the contrast between results obtained for monocytoid cells and those obtained for the fully permissive Vero cell line, we were then interested in finding out whether cell death by apoptosis could affect viral production. In fact a previous study reported no evidence of active replication of HSV-1 in U937 within 24 h p.i. (Feng et al, 1993) . Figure 4a shows a time-course for total (extracellular plus cellassociated) virus yield following exposure to HSV-2 for 1 h at different PFU/cell ratios, starting 24 h p.i.. Well-detectable levels of infectivity were observed at all PFU/cell ratios of inocula utilized. However at the higher dose of virus inoculum, i.e. at a dose able to induce a well-detectable level of apoptosis within 24 h p.i., virus yield did not increase with the ongoing of the culture. On the contrary, at lower doses of virus inoculum, virus yield grew exponentially with the incubation time. In addition, in the range of experimental conditions tested, independently of the MOI utilized and of the time required to obtain maximal production, virus yield reached an insuperable plateau. Figure 4b shows that HSV-2 not only replicated in U937 cells, but was also released in the supernatant as infectious virions. The course of the curves was very similar to that observed for total virus yield, but the absolute values of infectious particles released were at least ten times lower in comparison with total virus yield, at each point tested. Moreover, both total virus and extracellular virus yields resulted markedly lower compared to those obtained in the same experiment in Vero cells, as reported in Figure  4a and b. In repeated experiments maximal virus titers obtained in HSV-2 infected U937, using the same or different experimental conditions such as a lower MOI, did not significantly differ from those reported in the experiment shown in Figure 4 , and at least a hundred times lower in comparison with those usually obtained in Vero cells. Figure  4c shows that HSV-2 infection was associated with a clear inhibition of protein synthesis in U937 cells. However, the level of inhibition was lower in comparison with that obtained in Vero cells. The inhibition was prompt and halted about 24 h p.i., leveling off at approximately 50% of the control, as shown in Figure 4d . Our results do not allow us to distinguish whether this effect was due to reduced protein synthesis inhibition at single cell level or to failure to cause protein synthesis shut-off in part of the cell population. In addition, SDS ± PAGE analysis did not show any appreciable differences in the pattern of viral protein synthesis, detected by comparison with uninfected counterparts, between HSV-2-infected U937 and HSV-2-infected Vero cells (data not shown). Detection of large amounts of viral proteins in HSV-2-infected U937 cells was obtained using HSV-2-specific monoclonal antibodies and fluorescence microscopy. However, also using this technique to detect virus replication, the percentage of specific HSV-2-protein positive cells was lower in U937 cells with respect to Vero cells, at all time p.i. tested (data not shown). Nevertheless, first appearance of positivity for HSV-2-proteins, i.e. 4 ± 5 h p.i., was not delayed in U937 cells in comparison with that observed in Vero cells, indicating that the virus did not replicate in Vero cells faster than in U937 cells. Moreover, double fluorescence staining with anti-glycoprotein D monoclonal antibody and Hoechst, indicated that virus-specific proteins were detectable in apparently intact cells as well as in cells showing characteristic apoptotic morphology. Similarly, apoptosis was observed both in virus-protein positive and in virusprotein-negative cells ( Figure 5 ). Cycloheximide and moderate exposure to UV do not abrogate HSV-2-induced apoptosis in monocytoid cells
Finally, we were interested in obtaining more information on the mechanisms involved in cell death by apoptosis caused by HSV-2. To this purpose we tested whether the addition of cycloheximide (CHX) could interfere with the induction of apoptosis by HSV-2. CHX by itself, at 50 mg/ml, induced a well detectable level of apoptosis in untreated U937 cells, as shown by the DNA-electrophoresis-on-agarose-gel technique ( Figure 6a , lane 2). In fact, the U937 cell line has previously been shown to be sensitive to CHX-induced apoptosis (Martin et al, 1990) . However, the addition of CHX at 1 mg/ml, a dose which by itself induced quite a low level of apoptosis in U937 cells while still completely suppressing protein sysnthesis, did not prevent HSV-2-induced apoptosis as evaluated by fluorescence microscopy following acridine-orange-staining (Figure 6b ). Indeed, pre-treatment with CHX 1 h prior to infection seemed to enhance virusinduced apoptosis, detected at levels more than double those of untreated infected cultures, suggesting that de novo host or viral protein synthesis is dispensable in triggering apoptosis and that one or more virion-associated molecules could be responsible for this phenomenon. This hypothesis is consistent with the fact that HSV-2-induced apoptosis in U937 cells was highly dependent on the dose of virus inoculum. We have further investigated this possibility by using UV irradiation of the virus and by comparing the inactivation of infectivity with that of apoptosis-inducing activity. As shown in Figure 7 , both After labeling, cells were wahsed three times with PBS and lysed. Aliquots of lysates were then precipitated with TCA and the radioactivity incorporated was determined using a b-counter. Results are expressed as mean percentages in respect to uninfected controls, obtained from two independent experiments. (D) Kinetic of protein synthesis in U937 following infection with HSV-2. Protein synthesis measurement was performed as in (C). Results are expressed as cumulative mean percentages of uninfected control + S.D., calculated from two independent experiments performed in duplicate infectivity and apoptosis-inducing activity were strongly suppressed by prolonged exposure to UV light. However, when the virus was exposed to UV for a shorter time, we observed no strict link between the suppression of apoptosis-inducing activity and that of infectivity. In fact, only slight reductions of apoptosis were observed following infection with virus inocula in which infectivity was reduced a hundredfold by UV treatment.
Indomethacin treatment reduces induction of apoptosis by HSV-2
The cyclic pathway from arachidonate to eicosanoids could be one of the biochemical mechanisms involved in apoptosis caused by virus infection of cells of the monocyte/macrophage lineage, as we have shown with HIV-infected macrophages, in an experimental model in vitro (Mastino et al, 1993) . Thus, we added indomethacin 1 h before infection of U937 with HSV-2. When indomethacin (10 76 M) was added to HSV-2-infected cultures, the percentage of apoptotic cells was significantly reduced by about 40% compared with untreated infected cultures 24 h p.i. (Figure 8a ). The same dose of indomethacin did not significantly modify apoptosis in control uninfected U937 cells.
HSV-2-induced apoptosis in monocytoid cells is associated with a down-modulation of Bcl-2
Expression of the bcl-2 gene is one of the mechanisms associated with modulation of cell apoptosis during viral infections (Akbar et al, 1993; Boudet et al, 1996; Levine et al, 1996; Olsen et al, 1996) . Using flow cytometry, we thus analyzed Bcl-2 protein cellular level in U937 following HSV-2 infection. Results showed a clear virus-dose-dependent down-modulation of Bcl-2 in a high proportion of the cells 48 h following the infection at a MOI of 10 PFU/cell, i.e. in experimental conditions able to induce high level of apoptosis (Figure 8b ). Bcl-2 down-regulation could, therefore, be considered to be reasonably involved in HSV-induced apoptosis of monocytoid cells.
Discussion
Herpes simplex viruses are known to cause a lytic cycle of infection or persistently latent infection in cells of specific histological types. The mechanism of virus persistence is not fully understood but inhibition of apoptosis has been hypothesized to be one of the phenomena involved (Chou and Roizman, 1992) . For this reason, authors' interest has been mainly centered on the suppression of apoptosis by HSVs and on the viral molecules responsible for this inhibitory phenomenon (Leopardi and Roizman, 1996; Koyama and Miwa, 1997) . However, isolated reports indicated the apoptosis-inducing capacity of HSVs in vitro as well as in vivo (Tropea et al, 1995; Geiger et al, 1995) . Our results confirm the ability of viruses belonging to Herpesviridae family to induce apoptosis in infected cells and allow us to extend this observation to HSV-2 infection in vitro. We demonstrated a virus inoculum-dependent and time-dependent induction of apoptosis in U937, showing that apoptosis in this cell line, as a result of exposure to the virus, was not restricted to HSV-2 but was common to the herpes simplex viruses. However, we must note that levels of % apoptosis obtained using the HSV-1`F' strain were lower than those obtained using HSV-2. Nevertheless, utilizing an HSV-1 strain of different origin, the laboratory strain EB, we obtained percentages of apoptosis closer to those obtained with the HSV-2 strain`G', but consistently lower (data not shown). Thus, differences (6400) between the HSV-2 strain`G' and the HSV-1 strain`F', should be attributed part to`type-specific' and part to`strain-specific' characteristics.
Results of double fluorescence staining indicate that apparently intact cells as well as apoptotic cells were infected. Similarly, apoptosis was observed both in virusprotein-positive and in virus-protein-negative cells. Different hypotheses could account for this observation. One is that in some cells morphological changes leading to apoptosis could occur very rapidly after infection, not allowing the further progression of virus replication and the consequent production of detectable amounts of virus specific glycoproteins. On the other hand, it may be possible that part of the cells could be induced to die by apoptosis indirectly, without being infected by the virus. In this case cell death could be caused by exposure to apoptosisinducing cellular or viral products released by infected cells. Interestingly, a similar indirect effect was demonstrated by us using a different experimental model of virus infection in monocytic/macrophage cells in vitro (Mastino et al, 1993) . Our results indicate some of the mechanisms correlated with HSV-2-induced apoptosis, opening the way to identifying the viral components involved. We did not observe a strict quantitative link between the suppression of apoptosis-inducing activity and that of infectivity as shown by experiments with UV treatment. This fact indicates that virus particles in which full infectivity was abrogated, were still able to induce apoptosis, confirming the hypothesis that virion-associated molecules are involved in apoptosis induced by HSV-2. Interestingly, a similar uncoupling of suppression of infectivity and suppression of protein synthesis following HSV-2 irradiation with UV was observed many years ago (Fenwick and Walker, 1978) , demonstrating that structural proteins of herpesviruses, can shut off cellular protein synthesis. Therefore, virus-induced apoptosis in U937 cells could be linked, at least in part, to a herpesvirus-induced shut-off of protein synthesis in host cells. Moreover, UV-inactivated bovine herpesvirus 1 has recently been demonstrated to maintain its ability to induce apoptosis in bovine peripheral blood mononuclear cells (Hanon et al, 1996) . In addition, the fact that the cyclooxigenase inhibitor indomethacin reduced apoptosis caused by HSV-2 indicates that eicosanoid-release by U937 cells could be one of the mechanisms involved in virus-induced apoptosis. Prostaglandin E2 (PGE2) and other agents able to activate protein kinase A, have been shown to induce apoptosis in vitro (McConkey et al, 1990) as well as in vivo (Mastino et al, 1992) . However, we were not able to reproduce apoptosis in U937 cells by direct exposure of the cultures to PGE2 (data not shown), suggesting that mechanisms other than PGE2 production could be involved in indomethacin protection against HSV-2-induced apoptosis. Moreover, indomethacin treatment did not affect virus yield in monocytoid cells (data not shown). This excludes the possibility that indomethacin inhibitory action could be due to a protective effect against virus infection and/or replication. Interestingly, indomethacin has recently been shown to protect against stress-induced cellular damage through the modulation of heat shock factor 1 (Lee et al, 1995) . Considering that HSV infection could result in elevated expression of heat shock proteins (La Thangue et al, 1984) , protection by indomethacin against virusinduced apoptosis could be referred to a similar action.
In conclusion, our data demonstrate that the same HSV strains able to produce a lytic cycle of infection, without exhibiting any evidence of apoptosis in a fully permissive cell line, induced features characteristic of apoptosis in at least monocytoid cells. This result suggests that host cell factors could play a critical role in regulating the balance between the pro-apoptotic and the anti-apoptotic virus poential. Thus, even in the absence of any modification of the HSV genome, cells of specific histological types infected with HSV-2 or HSV-1 undergo a peculiar type of infection which differs from the classical productive-lytic and persistent-latent ones. In terms of kinetic and absolute quantity of virus production this kind of infection is located halfway between productive-lytic and persistent-latent infections and we propose identifying it as`apoptotic infection', according to the specificity of the cytophatic effect observed. Modulation of apoptosis could be one of the mechanisms by which the final fate of target cells could be regulated. In the case of inhibition of apoptosis, survival as persistently infected cells (nervous tissue) or death by necrosis during initial or recurrent infection (mucosal tissue) could occur; alternatively, in the case of induction, cell 76 M indomethacin (INDO) for 1 h or were left untreated and then mock-infected (MI) or infected with HSV-2 at a MOI of 1 PFU/cell or at a MOI of 10 PFU/cell. Cells were vigorously washed three times 1 h p.i. and resuspended in fresh growth medium with or without INDO. At 24 h p.i., percentage of apoptosis was evaluated as described in Figure 5 . Results, obtained in three independent experiments, are expressed as mean values+S.D. Statistical analysis by paired Student's t test. MOI=10 vs all other groups, P50.05; MOI=1 vs all other groups, P50.05. (B) For flow cytometry analysis of Bcl-2 protein, cells from mock-infected (Control) or HSV-2 (10 PFU/ml) infected cultures (HSV-2), 48 h p.i. were fixed in 4% paraformaldehyde in PBS for 20 min at room temperature and permeabilized in 0.1% Triton X-100 in PBS with 0.1% FCS for 5 min. After washing twice in PBS with 3% FCS, permeabilized cells were incubated with a rabbit polyclonal anti-human bcl-2 (Bcl-2) or irrelevant control antibodies (FlTC) for 30 min on ice and washed twice in PBS. Anti-bcl-2-stained cells were incubated with a FITC-conjugated goat anti-rabbit Ig antibody at a 1 : 30 dilution for 30 min on ice and then rinsed twice in PBS with 0.1% sodium azide. The dashed lines indicate the boundaries between the peaks of negative and positive cells which were arbitrarily set for control samples and maintained in all the corresponding anti-bcl-2/FITC-anti-rabbit stained samples. Similar results were obtained in three independent experiments death by apoptosis in the absence of an inflammatory reaction and in the presence of a limited and delayed spread of the virus could predominate (myeloid and lymphoid tissues). In fact, studies in progress in our laboratory indicate that induction of apoptosis by HSV is not restricted to monocytoid cells, but could also be observed in various cell lines of lymphoid lineage (unpublished data). HSV has been found to adopt specific active strategies in order to evade immune cell recognition (York et al, 1994) . Apoptosis of lymphomonocytes could be an additional mechanism by which the virus could control host immune response. Our results could, therefore, contribute to the clarification of the mechanisms by which herpesviruses exert their pathological action. Further investigations are necessary in order to better understand the role of apoptotic cell death during HSV-2 infection and the mechanisms involved in this phenomenon.
Materials and Methods
Viruses, cells and treatments
A`G' strain of HSV-2, originally obtained from the American Type Culture Collection, was used in most of the experiments. Virus stocks were produced by infecting at low multiplicity cultures of Vero (African green monkey kidney) cells propagated in MEM (HyClone Europe, Cramlington, UK) containing 10% fetal calf serum (FCS) (Life Technologies, Gaithersburg, MD) at 378C in a CO 2 incubator. Virus stocks gave a titer of approximately 1610 7 PFU/ml in Vero cells and were collected and stored in aliquots at 7808C. For experimental infection approximately 5610 5 U937 cells or confluent monolayers of Vero cells in 24/well plates, were inoculated, 24 h after cultures had been split, in complete medium (CM) with HSV-2 at different PFU/cell ratios and incubated at 378C in 5% CO 2 . CM consisted of RPMI 1640 (HyClone Europe) for U937 cells or MEM for Vero cells respectively, supplemented with 2 mM L-glutamine, 100 units/ml penicillin, 100 mg/ ml streptomycin and 10% heat-inactivated FCS. In experiments requiring inactivated virus, virus suspensions were placed in petri dishes (35 mm) and, in constant agitation, a volume of 1 ml was exposed, for varing times, to UV light at an intensity of 30 W from a germicidal lamp situated 10 cm above the sample. For mock-infection, target cells were exposed to control cellular extracts collected from uninfected Vero cells, manipulated and then stored in the same way as those containing the virus. Infected cultures were vigorously washed three times 1 h post-infection and the inocolum was replaced by fresh growth medium. Infected and control cells were grown at 378C in CM. In some experiments HL-60, as target cells, and in others HSV-1, as virus inoculum (Strain`F', originally obtained from ATCC, or strain EB, kindly provided by C.F. Perno, University of Rome`Tor Vergata'), produced and utilized as described for HSV-2, were also used. Indomethacin (10 76 M; Sigma, St. Louis, MO) was added to the cultures 1 h before infection. Cycloheximide (Sigma) was utilized at 1 ± 50 mg/ml, i.e. at concentrations which completely inhibited both host and virus protein synthesis in U937 and Vero cells. Flow cytometry analysis of isolated nuclei was performed using a method described for murine thymocytes (Nicoletti et al, 1991) , with minor modifications. Briefly, cells were collected from culture wells and washed twice in CM in 12675 mm polypropylene tubes (Falcon, Becton Dickinson Labware, Lincoln Park, NJ). Cell pellet was gently resuspended at room temperature in 1 ml of hypotonic solution consisting of: propidium iodide 50 mg/ml (Becton Dickinson, Mountain View, CA), 0.1% sodium citrate (Merck, Darmstadt, Germany) and 1% Triton X-100 (Sigma) in distilled water. The tubes were placed at 48C in the dark overnight. Flow cytometry analysis was subsequently performed using a FACscan flow cytometer (Beckton Dickinson). A correct threshold value was experimentally selected in order to exclude the majority of cell debris. Data collection was gated using adequate values of forward-and side-angle scatter to exclude remaining cell debris and large nuclei aggregates, and to include nuclei from apoptotic, necrotic and living cells. For each sample, 5000 events were acquired. Analysis of DNA fragmentation was carried out at single cell level using the TUNEL technique or at culture level by gel electrophoresis. Labeling of DNA strand breaks with fluorescein-dUTP by terminal deoxynucleotidyl transferase was performed using a commercial kit (`In situ cell death detection kit fluorescein'; Boehringer Mannheim, Mannheim, Germany) according to the manufacturer's instructions. Positive control consisted of cells treated with DNase 1 (1 mg/ml) for 10 min at room temperature. Analysis of labeled cells was performed both by fluorescence microscopy or flow cytometry. For flow cytometry, labeled cells were acquired and analyzed on a FACscan (Becton-Dickinson) using the FACscan program (BectonDickinson), following adequate gating by scatter parameters in order to exclude cell debris and large cell aggregates, and to include presumably apoptotic, necrotic and living cells. For each sample, 5000 events were acquired. For analysis of DNA fragmentation by gel electrophoresis, cells were washed in PBS and then lysed in 0.5 ml of lysis buffer (10 mM Tris, pH 7.4, 1 mM EDTA, pH 8.0, 0.2% Triton X-100) containing proteinase K (100 mg/ml) for 1 h at room temperature. Samples were then centrifuged at 13 000 r.p.m. for 15 min. DNA in the supernatants was precipitated with 5N NaCl in 1 volume of isopropanol for 1 h at 7208C. The DNA precipitates were recovered by centrifugation at 13 000 r.p.m., air dried for 15 min at room temperature, resuspended in TE buffer (10 mM Tris, pH 7.4, 1 mM EDTA, pH 8.0) containing RNase (100 mg/ml) and incubated for 1 h at 378C. Before electrophoresis, loading buffer (2% SDS, 15 mM EDTA, 0.25% w/v bromophenol blue, 50% v/v glycerol) was added to each sample in at a ratio of 1 : 5.
Evaluation of apoptosis
Virus titration
Extracellular virus or total virus (cell-associated plus extracellular virus) were titrated in supernatants from cultures or in aliquots of cell extracts obtained from cultures by freezing and thawing, respectively. Virus titers were determined by standard plaque assay on Vero cells. HSV-2 in U937 cells was also detected by using fluorescence microscopy and a commercial HSV-2-specific monoclonal antibody (Kallestad, Sanofi Diagnostics Pasteur, Chaska, MN) or a monoclonal antibody which recognizes HSV-2 glycoprotein D (LP2), kindly provided by Dr. S. Bacchetti (Hamilton, Canada).
Protein synthesis and PAGE
The kinetics and the amounts of protein synthesis in uninfected or HSV-2-infected U937 and Vero cells were studied. At different times after infection cells were labeled with 20 mCi/ml 35 S methionine (Amersham, Amersham Place, Buckinghamshire, UK) for 45 min. For protein synthesis measurements, cells were kept for 15 min in methionine-deprived culture medium, prior to labeling. After labeling, cells were washed three times with PBS and lysed in lysis buffer (2% SDS, 10% glycerol, 0.001% bromophenol blue, 0.1 M dithiothreitol, 0.625 M Tris-HCl pH 6.8). Aliquots of lysates were then precipitated with TCA and the radioactivity incorporated was determined using a bcounter (LKB Wallac, Turku, Finland) as previously described (Santoro et al, 1982) . Comparable amounts of samples, according to radioactivity counts, were analyzed by SDS ± PAGE in a vertical gel apparatus as described previously (Santoro et al, 1989) .
Flow cytometry analysis of Bcl-2 protein
Cells were fixed in 4% paraformaldehyde in PBS (pH 7.4) for 20 min at room temperature and permeabilized in 0.1% Triton X-100 in PBS with 0.1% FCS for 5 min. After washing twice in PBS with 3% FCS, permeabilized cells were incubated with a rabbit polyclonal anti-human bcl-2 (Pharmingen, San Diego, CA) or with irrelevant control antibodies for 30 min on ice and washed twice in PBS. Anti-bcl-2-stained cells were incubated with a FITCconjugated goat anti-rabbit Ig antibody (Harlan Sera-Lab, Crawley Down, UK) at a 1 : 30 dilution for 30 min on ice and then rinsed twice in PBS with 0.1% sodium azide. Stained cells were acquired and analyzed on a FACScan (Becton-Dickinson) as previously described for the TUNEL technique.
Statistical analysis
Analysis of data was performed using the SPSS statistical software system (version 6.0 for Windows, SPSS, Chicago, IL). Comparisons of means were carried out using the Duncan test, as a multiple range test, or the Student's t test for paired samples.
